Literature DB >> 16081934

Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis.

Raphaël Chiron1, Hélène Marchandin, François Counil, Estelle Jumas-Bilak, Anne-Marie Freydière, Gabriel Bellon, Marie-Odile Husson, Dominique Turck, François Brémont, Gérard Chabanon, Christine Segonds.   

Abstract

Patients with cystic fibrosis (CF) may be colonized with unusual gram-negative bacilli whose identification is difficult and clinical impact unclear. We describe the clinical and microbiological features of five colonizations with organisms belonging to the recently described genus Inquilinus in CF patients. Isolates were identified from Burkholderia cepacia selective medium by means of 16S rRNA analysis. All of them were resistant to colistin, penicillins, cephalosporins, and monobactams but exhibited a remarkable susceptibility to imipenem. One of the five patients was transiently colonized with a nonmucoid isolate, whereas the four other patients were persistently colonized over the period of follow-up (8 to 21 months) with mucoid isolates. Pulsed-field gel electrophoresis of SpeI-digested genomic DNA was powerful for strain genotyping and demonstrated the clonality of Inquilinus sp. colonization for the two patients tested. Clinical evolution after the onset of Inquilinus was heterogeneous, but for at least one patient the lung function worsened and eradication of Inquilinus sp. was unsuccessful despite several imipenem courses. Finally, Inquilinus spp. may represent a new threat for CF patients due to their mucoid characteristic, their multiresistant pattern to antibiotics, and their ability to persist in the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081934      PMCID: PMC1233925          DOI: 10.1128/JCM.43.8.3938-3943.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.

Authors:  D A Henry; M E Campbell; J J LiPuma; D P Speert
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 3.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  The chest roentgenogram in cystic fibrosis: a new scoring system.

Authors:  D Brasfield; G Hicks; S Soong; R E Tiller
Journal:  Pediatrics       Date:  1979-01       Impact factor: 7.124

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.

Authors:  C Segonds; T Heulin; N Marty; G Chabanon
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.

Authors:  D F Welch; M J Muszynski; C H Pai; M J Marcon; M M Hribar; P H Gilligan; J M Matsen; P A Ahlin; B C Hilman; S A Chartrand
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

8.  Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital.

Authors:  A Gouby; C Neuwirth; G Bourg; N Bouziges; M J Carles-Nurit; E Despaux; M Ramuz
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

9.  Pulmonary exacerbations in cystic fibrosis.

Authors:  Harvey R Rabin; Steven M Butler; Mary Ellen B Wohl; David E Geller; Andrew A Colin; Daniel V Schidlow; Charles A Johnson; Michael W Konstan; Warren E Regelmann
Journal:  Pediatr Pulmonol       Date:  2004-05

10.  Inquilinus limosus in patients with cystic fibrosis, Germany.

Authors:  Nele Wellinghausen; Andreas Essig; Olaf Sommerburg
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

View more
  13 in total

Review 1.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.

Authors:  Timothy J Kidd; Kay A Ramsay; Honghua Hu; Peter T P Bye; Mark R Elkins; Keith Grimwood; Colin Harbour; Guy B Marks; Michael D Nissen; Philip J Robinson; Barbara R Rose; Theo P Sloots; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

Review 5.  Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung.

Authors:  Quentin Menetrey; Pauline Sorlin; Estelle Jumas-Bilak; Raphaël Chiron; Chloé Dupont; Hélène Marchandin
Journal:  Genes (Basel)       Date:  2021-04-21       Impact factor: 4.096

6.  Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions.

Authors:  Susana P Lopes; Nuno F Azevedo; Maria O Pereira
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

7.  Bacterial community dynamics are linked to patterns of coral heat tolerance.

Authors:  Maren Ziegler; Francois O Seneca; Lauren K Yum; Stephen R Palumbi; Christian R Voolstra
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

8.  Inquilinus limosus and cystic fibrosis.

Authors:  Fadi Bittar; Anne Leydier; Emmanuelle Bosdure; Alexandre Toro; Martine Reynaud-Gaubert; Stéphanie Boniface; Nathalie Stremler; Jean-Christophe Dubus; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

9.  Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.

Authors:  Fadi Bittar; Hervé Richet; Jean-Christophe Dubus; Martine Reynaud-Gaubert; Nathalie Stremler; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

10.  Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.

Authors:  Henrique Douglas M Coutinho; Vivyanne S Falcão-Silva; Gregório Fernandes Gonçalves
Journal:  Int Arch Med       Date:  2008-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.